Optimizing lipase production by Bacillus subtilis on cheese whey and evaluating its antimicrobial, antibiofilm, anti virulence and biosafety properties
Open Access
- 1 April 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-21
Abstract
This study optimized lipase production using cheese whey, biofilm inhibition, and antibacterial efficacy of Bacillus subtilis (DSM 1088)derived lipase against Staphylococcus aureus (ATCC 6538). Peak lipase activity, growth rate, and inhibitory potential were observed at 48 h and 30 °C. Using Plackett-Burman and Central Composite Designs (PBD and CCD), whey, peptone, and agitation speed were identified as significant factors, achieving optimal lipase activity of 1314 U/mL and an inhibitory zone diameter (IZD) of 48 mm against S. aureus. Partial purification through ammonium sulfate precipitation and dialysis increased partial purified lipase (PPL) activity by twofold and fivefold, respectively. PPL exhibited effective bactericidal properties with a minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of 1/8 and 1/16, confirming a bactericidal effect (MIC/MBC ratio ≤ 2). Biofilm inhibition assays demonstrated 95% biofilm reduction at 80 µg/mL PPL, with SEM imaging revealing significant biofilm matrix disruption. Time-kill assays showed concentration-dependent bactericidal action, while inhibition of hemolysin and protease activities (25–100%) indicated reduced S. aureus pathogenicity. Cytotoxicity assays on normal liver cells showed an IC50 > 300 µg/mL, indicating low toxicity. GC/MS analysis of oil waste before degradation identified predominantly oleic acid 3-hydroxypropyl ester and octadecane derivatives, while after degradation, it revealed enriched free fatty acids including myristic, palmitic, linoleic, and oleic acids, which could enhance antimicrobial efficacy. Molecular docking suggested that PPL inhibits essential bacterial enzymes (folic acid synthetase, RNA polymerase, DNA gyrase), potentially disrupting DNA synthesis and promoting cell death. These findings highlight B. subtilis-derived lipase as a promising bio-agent for combating biofilm-associated, drug-resistant pathogens with clinical and industrial applications.Keywords
Funding Information
- Ain Shams University
This publication has 54 references indexed in Scilit:
- Exploring Bacillus subtilis: Ecology, biotechnological applications, and future prospectsJournal of Basic Microbiology, 2024
- Bacillus and Streptomyces spp. as hosts for production of industrially relevant enzymesApplied Microbiology and Biotechnology, 2024
- Flourishing Antibacterial Strategies for Osteomyelitis TherapyAdvanced Science, 2023
- Simultaneous action of microbial phospholipase C and lipase on model bacterial membranes – Modeling the processes crucial for bioaugmentationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2021
- Gamma‐aminobutyric acid production by Lactobacillus brevis A3: Optimization of production, antioxidant potential, cell toxicity, and antimicrobial activityFood Science & Nutrition, 2020
- Lipase-catalyzed synthesis of palmitanilide: Kinetic model and antimicrobial activity studyEnzyme and Microbial Technology, 2016
- Cheese whey: A potential resource to transform into bioprotein, functional/nutritional proteins and bioactive peptidesBiotechnology Advances, 2015
- Optimization of medium composition for the production of antimicrobial activity by Bacillus subtilis B38Biotechnology Progress, 2009
- Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinationsBiochemical Pharmacology, 2006
- Lipase assay in soils by copper soap colorimetryAnalytical Biochemistry, 2004